Business / Finance

RSS

AcelRx completes private placement of common stock

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, announced today that it completed its previously announced private placement of common stock and warrants to purchase common stock on June 1, 2012.

4 Jun 2012

ShangPharma celebrates 10th anniversary of partnership with Lilly

ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today celebrated the 10th anniversary of its partnership with Eli Lilly and Company.

4 Jun 2012

MARIJUANA announces corporate name change to Hemp

MARIJUANA, INC. is proud to announce a corporate name change to Hemp, Inc. The change goes into effect immediately.

4 Jun 2012

CTI acquires world-wide rights to S*BIO’s pacritinib

Cell Therapeutics, Inc., announced today that it has completed its acquisition gaining world-wide rights to S*BIO Pte Ltd.'s pacritinib.

4 Jun 2012

Global generic pharmaceuticals market to reach $231.00 billion in 2017 at 9.29% CAGR

The global generic pharmaceuticals market is likely to witness strong growth in the next few years owing to the patent expiration of key blockbuster drugs and the judicious cost containment efforts of governments and healthcare service providers worldwide.

2 Jun 2012

Ventas agrees to sell 5,200,000 shares of common stock to Citigroup

Ventas, Inc. announced today that it has agreed to sell 5,200,000 shares of its common stock to Citigroup, as sole underwriter, in an underwritten public offering.

1 Jun 2012

Nepstar first quarter revenue increases 1.3% to RMB625.8M

China Nepstar Chain Drugstore Ltd., the largest retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the first quarter ended March 31, 2012.

31 May 2012

Kona Medical raises $30 million in Series C financing

Kona Medical, Inc. today announced it has raised $30 million in Series C financing to advance its novel hypertension therapy.

31 May 2012

Stiefel to acquire WBI-1001 licensing rights from Welichem

Stiefel, a GSK company, and Welichem Biotech Inc., have entered into an agreement for the acquisition by Stiefel of exclusive development and commercialization rights to the novel anti-inflammatory agent, WBI-1001, in all territories in the world outside of China, Taiwan, Macao and Hong Kong.

31 May 2012

SQI Diagnostics reports net loss of $1,350,000 for second quarter 2012

SQI Diagnostics Inc., a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced its financial and operational results for the three and six months ended March 31, 2012.

31 May 2012

BIOREM first quarter revenue decreases 12.5% to $3,267,000

BIOREM Inc. announced today its results for the first quarter of 2012. Q1, 2012 revenue was $3,267,000, which is down $465,000 or 12.5% over the comparative period in the prior year.

31 May 2012

China Shenghuo first quarter total revenue increases 20.5% to $11.4M

China Shenghuo Pharmaceutical Holdings, Inc., today reported financial results for the first quarter ended March 31, 2012.

31 May 2012

AssureRx closes $12.5M Series C financing

AssureRx Health, Inc. today announced the closing of a $12.5 million Series C financing. The personalized medicine company, which provides clinically-relevant information to help physicians select the right drug for individual neuropsychiatric patients, will use the funds to increase commercial activities for its two flagship pharmacogenomic products, GeneSightRx Psychotropic and GeneSightRx® ADHD, as well as next generation product development activities.

31 May 2012

Medical imaging revenue market for CEE and Russia to reach $2.34 billion in 2015

Rising disease incidence and growing awareness about health issues will boost demand for medical imaging services across Central and Eastern Europe (CEE).

30 May 2012

RBCC negotiates potential joint venture with AMBS for traumatic brain injury treatment

Rainbow BioSciences, the biotech subsidiary of Rainbow Coral Corp., continues due diligence toward an agreement to help develop a promising new treatment for Traumatic Brain Injury (TBI), concern continues to grow over the troubling incidence of TBI among athletes and soldiers.

30 May 2012

Al Jazeera business program examines fight against malaria

Al Jazeera's "Counting the Cost" program on Saturday focused on the fight against malaria and the "business behind its treatment and prevention." According to the program, progress against malaria "is being threatened in these tough economic times. There is a $3 billion shortfall in funding for malaria treatment and prevention."

30 May 2012

Towers Watson acquires Extend Health

Towers Watson, a leading global professional services company, today announced the completion of its acquisition of Extend Health, Inc., which operates the largest private Medicare exchange in the United States.

30 May 2012

Partnership between Molecular Profiles and GEA Process Engineering to demonstrate benefits of new technology

Molecular Profiles, a leading specialist contract research and manufacturing organisation, announces that it has entered into a strategic collaboration with GEA Process Engineering - the company behind the world-recognized GEA Niro spray drying technology.

29 May 2012